John Savin
Recent Quotes
"Sales for CYTX's Celution device were $7.1M in FY/13."
—
John Savin, Edison Investment Research
(3/20/14)
more >
"CYTX's phase 2 trial of Athena could lead to a partnership deal in 2015."
—
John Savin, Edison Investment Research
(2/4/14)
more >
Due to permission requirements, not all quotes are shown.
